vs
Ramaco Resources, Inc.（METC）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Ramaco Resources, Inc.的1.7倍（$207.3M vs $121.0M），Ramaco Resources, Inc.净利率更高（-11.0% vs -62.0%，领先51.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -27.7%），Ramaco Resources, Inc.自由现金流更多（$-17.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -22.7%）
Ramaco Resources, Inc.是一家总部位于美国的矿业企业，主营高等级冶金煤生产，在阿巴拉契亚地区运营多处采矿资产，产品供应全球钢铁制造商及工业客户，核心业务为可持续、低成本的冶金煤开采与分销。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
METC vs RARE — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $121.0M | $207.3M |
| 净利润 | $-13.3M | $-128.6M |
| 毛利率 | 15.8% | — |
| 营业利润率 | -12.0% | -54.7% |
| 净利率 | -11.0% | -62.0% |
| 营收同比 | -27.7% | 25.9% |
| 净利润同比 | -5468.2% | 3.5% |
| 每股收益（稀释后） | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $207.3M | ||
| Q3 25 | $121.0M | $159.9M | ||
| Q2 25 | $153.0M | $166.5M | ||
| Q1 25 | $134.7M | $139.3M | ||
| Q4 24 | $170.9M | $164.6M | ||
| Q3 24 | $167.4M | $139.5M | ||
| Q2 24 | $155.3M | $147.0M | ||
| Q1 24 | $172.7M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $-13.3M | $-180.4M | ||
| Q2 25 | $-14.0M | $-115.0M | ||
| Q1 25 | $-9.5M | $-151.1M | ||
| Q4 24 | $3.9M | $-133.2M | ||
| Q3 24 | $-239.0K | $-133.5M | ||
| Q2 24 | $5.5M | $-131.6M | ||
| Q1 24 | $2.0M | $-170.7M |
| Q4 25 | — | — | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 12.3% | — | ||
| Q1 25 | 15.2% | — | ||
| Q4 24 | 20.4% | — | ||
| Q3 24 | 19.5% | — | ||
| Q2 24 | 21.0% | — | ||
| Q1 24 | 19.1% | — |
| Q4 25 | — | -54.7% | ||
| Q3 25 | -12.0% | -106.9% | ||
| Q2 25 | -9.1% | -64.8% | ||
| Q1 25 | -8.9% | -102.6% | ||
| Q4 24 | 3.7% | -74.3% | ||
| Q3 24 | 1.0% | -94.6% | ||
| Q2 24 | 3.5% | -79.1% | ||
| Q1 24 | 1.9% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | -11.0% | -112.8% | ||
| Q2 25 | -9.1% | -69.0% | ||
| Q1 25 | -7.0% | -108.5% | ||
| Q4 24 | 2.3% | -80.9% | ||
| Q3 24 | -0.1% | -95.7% | ||
| Q2 24 | 3.6% | -89.5% | ||
| Q1 24 | 1.2% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | $0.06 | $-1.34 | ||
| Q3 24 | $-0.03 | $-1.40 | ||
| Q2 24 | $0.08 | $-1.52 | ||
| Q1 24 | $0.00 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $193.8M | $421.0M |
| 总债务越低越好 | $116.3M | — |
| 股东权益账面价值 | $526.9M | $-80.0M |
| 总资产 | $849.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.22× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | $193.8M | $202.5M | ||
| Q2 25 | $28.1M | $176.3M | ||
| Q1 25 | $43.5M | $127.1M | ||
| Q4 24 | $33.0M | $174.0M | ||
| Q3 24 | $22.9M | $150.6M | ||
| Q2 24 | $27.6M | $480.7M | ||
| Q1 24 | $30.5M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | $116.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $88.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $526.9M | $9.2M | ||
| Q2 25 | $347.4M | $151.3M | ||
| Q1 25 | $355.2M | $144.2M | ||
| Q4 24 | $362.8M | $255.0M | ||
| Q3 24 | $361.8M | $346.8M | ||
| Q2 24 | $366.1M | $432.4M | ||
| Q1 24 | $372.3M | $140.3M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $849.7M | $1.2B | ||
| Q2 25 | $674.6M | $1.3B | ||
| Q1 25 | $685.7M | $1.3B | ||
| Q4 24 | $674.7M | $1.5B | ||
| Q3 24 | $645.4M | $1.5B | ||
| Q2 24 | $659.2M | $1.6B | ||
| Q1 24 | $674.0M | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.24× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-17.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | -14.5% | -48.6% |
| 资本支出强度资本支出/营收 | 13.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-24.7M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $-1.4M | $-91.4M | ||
| Q2 25 | $-4.3M | $-108.3M | ||
| Q1 25 | $26.0M | $-166.5M | ||
| Q4 24 | $15.7M | $-79.3M | ||
| Q3 24 | $37.4M | $-67.0M | ||
| Q2 24 | $34.4M | $-77.0M | ||
| Q1 24 | $25.2M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $-17.5M | $-92.7M | ||
| Q2 25 | $-19.8M | $-110.7M | ||
| Q1 25 | $7.6M | $-167.8M | ||
| Q4 24 | $5.1M | $-79.5M | ||
| Q3 24 | $25.6M | $-68.6M | ||
| Q2 24 | $20.3M | $-79.0M | ||
| Q1 24 | $6.5M | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | -14.5% | -58.0% | ||
| Q2 25 | -13.0% | -66.5% | ||
| Q1 25 | 5.6% | -120.5% | ||
| Q4 24 | 3.0% | -48.3% | ||
| Q3 24 | 15.3% | -49.2% | ||
| Q2 24 | 13.1% | -53.7% | ||
| Q1 24 | 3.7% | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 13.3% | 0.8% | ||
| Q2 25 | 10.2% | 1.5% | ||
| Q1 25 | 13.7% | 1.0% | ||
| Q4 24 | 6.2% | 0.1% | ||
| Q3 24 | 7.0% | 1.2% | ||
| Q2 24 | 9.1% | 1.4% | ||
| Q1 24 | 10.8% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.06× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.21× | — | ||
| Q1 24 | 12.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
METC
| Export Coal Revenues | $73.0M | 60% |
| Domestic Coal Revenues | $48.0M | 40% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
